Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer von Li, Qingjian, Qin, Tao, Bi, Zhuofei, Hong, Huangming, Ding, Lin, Chen, Jiewen, Wu, Wei, Lin, Xiaorong, Fu, Wenkui, Zheng, Fang, Yao, Yandan, Luo, Man-Li, Saw, Phei Er, Wulf, Gerburg M., Xu, Xiaoding, Song, Erwei, Yao, Herui, Hu, Hai

Volltext

Fusobacterium and Colorectal Cancer von Zhou, Ziwei, Chen, Jiewen, Yao, Herui, Hu, Hai

Volltext

CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness von Su, Shicheng, Chen, Jianing, Yao, Herui, Liu, Jiang, Yu, Shubin, Lao, Liyan, Wang, Minghui, Luo, Manli, Xing, Yue, Chen, Fei, Huang, Di, Zhao, Jinghua, Yang, Linbin, Liao, Dan, Su, Fengxi, Li, Mengfeng, Liu, Qiang, Song, Erwei

Volltext

The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis von Zheng, Fang, Chen, Jianing, Zhang, Xiaoqian, Wang, Zifeng, Chen, Jiewen, Lin, Xiaorong, Huang, Hongyan, Fu, Wenkui, Liang, Jing, Wu, Wei, Li, Bo, Yao, Herui, Hu, Hai, Song, Erwei

Volltext

LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis von Huang, Fengting, Chen, Wenying, Peng, Juanfei, Li, Yuanhua, Zhuang, Yanyan, Zhu, Zhe, Shao, Chunkui, Yang, Wanling, Yao, Herui, Zhang, Shineng

Volltext

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer von Liu, Jieqiong, Wang, Ying, Tian, Zhenluan, Lin, Ying, Li, Hengyu, Zhu, Zhaowen, Liu, Qiang, Su, Shicheng, Zeng, Yinduo, Jia, Weijuan, Yang, Yaping, Xu, Shengqiang, Yao, Herui, Jiang, Wen, Song, Erwei

Volltext

Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer von Gong, Chang, Yao, Yandan, Wang, Ying, Liu, Bodu, Wu, Wei, Chen, Jianing, Su, Fengxi, Yao, Herui, Song, Erwei

Volltext

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program von Su, Shicheng, Zhao, Qiyi, He, Chonghua, Huang, Di, Liu, Jiang, Chen, Fei, Chen, Jianing, Liao, Jian-You, Cui, Xiuying, Zeng, Yunjie, Yao, Herui, Su, Fengxi, Liu, Qiang, Jiang, Shanping, Song, Erwei

Volltext

Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation von Nie, Yan, Chen, Jianing, Huang, Di, Yao, Yandan, Chen, Jiewen, Ding, Lin, Zeng, Jiayi, Su, Shicheng, Chao, Xue, Su, Fengxi, Yao, Herui, Hu, Hai, Song, Erwei

Volltext

Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer von Huang, Di, Chen, Xueman, Zeng, Xin, Lao, Liyan, Li, Jiaqian, Xing, Yue, Lu, Yiwen, Ouyang, Qian, Chen, Jianing, Yang, Linbin, Su, Fengxi, Yao, Herui, Liu, Qiang, Su, Shicheng, Song, Erwei

Volltext

CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3 von Chen, Jingqi, Yao, Yandan, Gong, Chang, Yu, Fengyan, Su, Shicheng, Chen, Jianing, Liu, Bodu, Deng, Hui, Wang, Fengsong, Lin, Ling, Yao, Herui, Su, Fengxi, Anderson, Karen S., Liu, Qiang, Ewen, Mark E., Yao, Xuebiao, Song, Erwei

Volltext

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 von Zhu, Yinghua, Liu, Yujie, Zhang, Chao, Chu, Junjun, Wu, Yanqing, Li, Yudong, Liu, Jieqiong, Li, Qian, Li, Shunying, Shi, Qianfeng, Jin, Liang, Zhao, Jianli, Yin, Dong, Efroni, Sol, Su, Fengxi, Yao, Herui, Song, Erwei, Liu, Qiang

Volltext

Blocking the recruitment of naive CD4＋ T cells reverses immunosuppression in breast cancer von Su, Shicheng, Liao, Jianyou, Liu, Jiang, Huang, Di, He, Chonghua, Chen, Fei, Yang, LinBing, Wu, Wei, Chen, Jianing, Lin, Ling, Zeng, Yunjie, Ouyang, Nengtai, Cui, Xiuying, Yao, Herui, Su, Fengxi, Huang, Jian-dong, Lieberman, Judy, Liu, Qiang, Song, Erwei

Volltext

NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition von Zhang, Wei, Guo, Qiannan, Liu, Guoying, Zheng, Fang, Chen, Jianing, Huang, Di, Ding, Linxiaoxiao, Yang, Xing, Song, Erwei, Xiang, Yanqun, Yao, Herui

Volltext

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients von Li, Huiping, Liu, Jiang, Chen, Jianing, Wang, Huiyun, Yang, Linbin, Chen, Fei, Fan, Siting, Wang, Jing, Shao, Bin, Yin, Dong, Zeng, Musheng, Li, Mengfeng, Li, Jun, Su, Fengxi, Liu, Qiang, Yao, Herui, Su, Shicheng, Song, Erwei

Volltext

miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα von Luo, Ming, Ding, Ling, Li, Qingjian, Yao, Herui

Volltext

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive br... von Yu, Yunfang, He, Zifan, Ouyang, Jie, Tan, Yujie, Chen, Yongjian, Gu, Yang, Mao, Luhui, Ren, Wei, Wang, Jue, Lin, Lili, Wu, Zhuo, Liu, Jingwen, Ou, Qiyun, Hu, Qiugen, Li, Anlin, Chen, Kai, Li, Chenchen, Lu, Nian, Li, Xiaohong, Su, Fengxi, Liu, Qiang, Xie, Chuanmiao, Yao, Herui

Volltext

Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade von Lin, Xiaorong, Dinglin, Xiaoxiao, Cao, Siting, Zheng, Senyou, Wu, Cheng, Chen, Wenying, Li, Qingjian, Hu, Qian, Zheng, Fang, Wu, Zhiyong, Lin, De-Chen, Yao, Yandan, Xu, Xiaoding, Xie, Zhi, Liu, Qiang, Yao, Herui, Hu, Hai

Volltext

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial von Liu, Jieqiong, Liu, Qiang, Li, Ying, Li, Qian, Su, Fengxi, Yao, Herui, Su, Shicheng, Wang, Quanren, Jin, Liang, Wang, Ying, Lau, Wan Yee, Jiang, Zefei, Song, Erwei

Volltext

Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5 von Zhu, Yinghua, Yu, Fengyan, Jiao, Yu, Feng, Juan, Tang, Wei, Yao, Herui, Gong, Chang, Chen, Jianing, Su, Fengxi, Zhang, Yan, Song, Erwei

Volltext